Literature DB >> 28812600

Prostate cancer: Chemotherapy outcomes similar in mCRPC.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28812600     DOI： 10.1038/nrclinonc.2017.134

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.

Authors:  Stéphane Oudard; Karim Fizazi; Lisa Sengeløv; Gedske Daugaard; Fred Saad; Steinbjørn Hansen; Marie Hjälm-Eriksson; Jacek Jassem; Antoine Thiery-Vuillemin; Orazio Caffo; Daniel Castellano; Paul N Mainwaring; John Bernard; Liji Shen; Mustapha Chadjaa; Oliver Sartor
Journal:  J Clin Oncol       Date:  2017-07-28       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.